Larimar Therapeutics
LRMR
#8139
Rank
HK$2.57 B
Marketcap
HK$24.61
Share price
-2.48%
Change (1 day)
-11.16%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2026 (TTM): -HK$15.21

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$15.29. In 2025 the company made an earnings per share (EPS) of -HK$17.32 a decrease over its 2024 EPS that were of -HK$10.19.

EPS history for Larimar Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$15.21-12.2%
2025-HK$17.3270%
2024-HK$10.19
2022-HK$12.07-48.15%
2021-HK$23.28-14.27%
2020-HK$27.16